| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | +106.5% |
| R&D Expense | $182K | -39.5% |
| SG&A Expense | $12.2M | +27.1% |
| Operating Income | -$7.4M | +4.6% |
| Interest Expense | $500K | +0.0% |
| Net Income | -$7.8M | +5.3% |
| EPS (Basic) | -$2.33 | +11.1% |
| EPS (Diluted) | -$2.33 | +11.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | -51.9% |
| Accounts Receivable | $1.2M | +97.5% |
| Inventory | $482K | +66.5% |
| Current Assets | $6.8M | -41.8% |
| Total Assets | $7.1M | -40.4% |
| Current Liabilities | $9.6M | +483.1% |
| Total Liabilities | $9.6M | +24.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.0M | +24.4% |
| Financing Cash Flow | -$119K | -101.6% |
| Stockholders' Equity |
| -$2.6M |
| -163.2% |